Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Neoplasms × Bleomycin × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms, Second Primary 1 Desmoid Tumors 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 69 Blood Specimen Collection 60 palbociclib 37 Trastuzumab 31 Letrozole 26 Immunohistochemistry 26 Anastrozole 24 Drug Therapy 23 Radiotherapy 21 Gene Expression Profiling 20 Amplified Fragment Length Polymorphism Analysis 20 Mastectomy, Segmental 19 Biopsy 19 Tamoxifen 18 exemestane 17 Interviews as Topic 17 ribociclib 16 Mastectomy 16 Fulvestrant 16 Paclitaxel 15 Magnetic Resonance Spectroscopy 15 High-Energy Shock Waves 14 Psychiatric Rehabilitation 13 Polymerase Chain Reaction 13 Observation 13 Microarray Analysis 13 Capecitabine 13 Neoadjuvant Therapy 12 trastuzumab deruxtecan 11 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06683404 2024-11-12

GISEL

Istituto Oncologico Veneto IRCCS

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡